These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 18469857
1. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, Chan AT, Sung JJ, Tao Q. Oncogene; 2008 Sep 04; 27(39):5267-76. PubMed ID: 18469857 [Abstract] [Full Text] [Related]
2. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q. Oncogene; 2007 Feb 08; 26(6):934-44. PubMed ID: 16862168 [Abstract] [Full Text] [Related]
3. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q. Oncogene; 2006 Feb 16; 25(7):1070-80. PubMed ID: 16247458 [Abstract] [Full Text] [Related]
4. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. Tshuikina M, Jernberg-Wiklund H, Nilsson K, Oberg F. Exp Hematol; 2008 Dec 16; 36(12):1673-1681. PubMed ID: 18922617 [Abstract] [Full Text] [Related]
5. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q. Clin Cancer Res; 2007 Oct 01; 13(19):5756-62. PubMed ID: 17908965 [Abstract] [Full Text] [Related]
6. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C. Oncogene; 2009 Jul 02; 28(26):2466-75. PubMed ID: 19448674 [Abstract] [Full Text] [Related]
7. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Cheung HW, Ching YP, Nicholls JM, Ling MT, Wong YC, Hui N, Cheung A, Tsao SW, Wang Q, Yeun PW, Lo KW, Jin DY, Wang X. Mol Carcinog; 2005 Aug 02; 43(4):237-45. PubMed ID: 15937956 [Abstract] [Full Text] [Related]
8. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW. Genes Chromosomes Cancer; 2007 Feb 02; 46(2):171-80. PubMed ID: 17099870 [Abstract] [Full Text] [Related]
9. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, Srivastava G, Yu J, Sung JJ, Chan AT, Ma D, Tao Q, Han W. Cancer Res; 2009 Jun 15; 69(12):5194-201. PubMed ID: 19509237 [Abstract] [Full Text] [Related]
11. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U. Leukemia; 2010 May 15; 24(5):992-1000. PubMed ID: 20237505 [Abstract] [Full Text] [Related]
12. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma. Chow LS, Lo KW, Kwong J, Wong AY, Huang DP. Oncol Rep; 2004 Oct 15; 12(4):781-7. PubMed ID: 15375500 [Abstract] [Full Text] [Related]
13. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma. Zhou L, Feng X, Shan W, Zhou W, Liu W, Wang L, Zhu B, Yi H, Yao K, Ren C. Oncology; 2007 Oct 15; 72(5-6):357-63. PubMed ID: 18187958 [Abstract] [Full Text] [Related]
14. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. Yi B, Tan SX, Tang CE, Huang WG, Cheng AL, Li C, Zhang PF, Li MY, Li JL, Yi H, Peng F, Chen ZC, Xiao ZQ. J Cell Biochem; 2009 Apr 01; 106(5):858-66. PubMed ID: 19160382 [Abstract] [Full Text] [Related]
15. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E. Breast Cancer Res; 2008 Apr 01; 10(5):R82. PubMed ID: 18826564 [Abstract] [Full Text] [Related]
16. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L. Oral Oncol; 2007 Jan 01; 43(1):82-7. PubMed ID: 16807071 [Abstract] [Full Text] [Related]
17. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML. Cancer Lett; 2006 Mar 28; 234(2):184-92. PubMed ID: 15885884 [Abstract] [Full Text] [Related]
18. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene. Tshuikina M, Nilsson K, Oberg F. Gene; 2008 Mar 15; 410(2):259-67. PubMed ID: 18242011 [Abstract] [Full Text] [Related]
19. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation. Luo X, Xiong X, Shao Q, Xiang T, Li L, Yin X, Li X, Tao Q, Ren G. Oncotarget; 2017 Jul 25; 8(30):48875-48888. PubMed ID: 28388578 [Abstract] [Full Text] [Related]
20. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, Bachmann A, Ritter TM, Dondog B, Ly R, Bosch FX, Zawatzky R, Rösl F. Cancer Res; 2009 Nov 15; 69(22):8718-25. PubMed ID: 19887612 [Abstract] [Full Text] [Related] Page: [Next] [New Search]